iGMDRD53
Canonical SMILES: CC(C(C1=CC=CC=C1)O)NC
InChI: InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10+/m0/s1
InChI Key: KWGRBVOPPLSCSI-WCBMZHEXSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Standard NamePSEUDOEPHEDRINE CHEMBLCHEMBL1590 Pubchem CID7028 KEGG Drug IDD08449 DRUGBANK IDDB00852 Drug StatusAlone Drug targets (TTD)DAP000195 Drug TypeSmall Molecule |
Drug Class:
Adrenergic AgonistsAdrenergic alpha-1 Receptor AgonistsAdrenergic alpha-2 Receptor AgonistsAdrenergic alpha-AgonistsAlcoholsAlpha-and Beta-adrenergic AgonistsAminesAmino AlcoholsAmphetaminesAnti-Asthmatic AgentsAutonomic AgentsBronchodilator AgentsCardiovascular AgentsCombined Inhibitors of Serotonin/Norepinephrine ReuptakeEthylaminesNasal DecongestantsNasal Decongestants for Systemic UseNasal PreparationsPeripheral Nervous System AgentsPhenethylaminesPropanolaminesPropanolsRespiratory SystemRespiratory System AgentsSympathomimetic (Adrenergic) AgentsSympathomimeticsVasoconstrictor AgentsDrug Targets:
SLC6A2 (P23975)SLC6A3 (Q01959)ADRA1A (P35348)ADRA2A (P08913)SLC6A4 (P31645)ADRB2 (P07550)ADRB1 (P08588)NFATC1 (O95644)TNF (P01375)Nuclear factor kappa-light-chain-enhancer of activated B cellsATF1 (P18846)IL2 (P60568)Drug Pathways:
Neuroactive ligand-receptor interactionVascular smooth muscle contractionPhenylalanine metabolism Biosynthesis of alkaloids derived from shikimate pathway Metabolic pathwaysDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Loading, please wait...
Gene ID | Gene Name | Model Num. |
---|---|---|
54498 | SMOX | 1 |
Showing 1 to 1 of 1 rows
Gene in drug-gene network: Network Plot

Models in PSEUDOEPHEDRINE
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |